Financhill
Back

Akero Therapeutics Quote, Financials, Valuation and Earnings

America's Cash Bubble Set to Burst on December 13, 2023

Watch His Free Video Here
Buy
59

AKRO
Akero Therapeutics

Last Price:
17.90
Seasonality Move:
-0.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Tech insider: "Watch your mailbox"

Full story here.

Akero Therapeutics Price Quote

$17.90
+0.24 (+1.36%)
(Updated: December 4, 2023 at 5:55 PM ET)

Akero Therapeutics Key Stats

Buy
59
Akero Therapeutics (AKRO) is a Buy

Day range:
$16.12 - $17.70
52-week range:
$11.25 - $58.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.69%

Volume:
941.7K
Avg. volume:
1.3M
1-year change:
-61.35%
Market cap:
$983.8M
Revenue:
$0
EPS:
$-2.35

How Much Does Akero Therapeutics Make?

Data Unavailable

Is Akero Therapeutics Growing As A Company?

Data Unavailable

Akero Therapeutics Stock Price Performance

What Is Akero Therapeutics 52-Week High & Low?

Akero Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Akero Therapeutics?

Is Akero Therapeutics Cash Flow Positive?

  • What Is AKRO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$122.2M
  • What Is Akero Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $355.5M
  • What Is Akero Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$337.9M

Akero Therapeutics Return On Invested Capital

Data Unavailable

Akero Therapeutics Earnings Date & Stock Price

Akero Therapeutics Competitors

  • Who Are Akero Therapeutics's Competitors?
    Below is a list of companies who compete with Akero Therapeutics or are related in some way:
    • Acurx Pharmaceuticals Inc (ACXP)
    • Alnylam Pharmaceuticals Inc (ALNY)
    • 89bio Inc (ETNB)
    • Mirati Therapeutics Inc (MRTX)
    • Protagenic Therapeutics Inc (PTIX)

Akero Therapeutics Dividend Yield

Data Unavailable

Akero Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -2.31%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 42.88
Upside from Last Price: 142.78%

Major Shareholders

  • How many AKRO shares are owned by institutional investors?
    82.4M AKRO shares are owned by institutional investors
  • How many AKRO shares are owned by insiders?
    997.8K AKRO shares are owned by insiders